There’s something undeniably magnetic about the idea of Jacob Elordi and Scarlett Johansson sharing a screen again. Not because they’re a couple—though that’s always a juicy angle—but because their presence alone can turn a project into a cultural event. Ari Aster’s new thriller, Scapegoat, is already generating whispers of anticipation, even before the first frame is shot. But what really makes this intriguing isn’t just the names attached; it’s the collision of two distinct creative worlds, each with its own baggage, ambitions, and audience expectations. Personally, I think this pairing could either be a masterstroke or a misfire, depending on how Aster navigates the tension between his signature horror sensibilities and the star power of Johansson, whose recent roles have leaned more toward prestige drama than psychological terror. What makes this particularly fascinating is the question of whether Aster will let the actors’ gravitas overshadow his penchant for discomfort, or if he’ll use their fame as a Trojan horse to lure audiences into a more experimental narrative. If you take a step back and think about it, this isn’t just about a movie—it’s about the evolving role of A-list actors in niche genres, and how their involvement can either elevate or dilute a director’s artistic vision.
Aster’s career has been a study in contrasts. His debut, Hereditary, was a gut-punch of familial grief and cosmic horror, a film that still haunts critics’ lists years later. But since then, his work has oscillated between critical acclaim and polarizing reception. Midsommar was a bold, sun-drenched nightmare that divided audiences, while Beau Is Afraid felt like a fever dream of self-indulgence. Now, with Scapegoat, he’s returning to the well of psychological unease that made him a household name. What many people don’t realize is that Aster’s obsession with trauma and dysfunction isn’t just a stylistic choice—it’s a reflection of his own creative insecurities. He’s openly admitted that Hereditary feels like a shadow over his subsequent work, a benchmark he’s struggled to match. This raises a deeper question: Is Scapegoat another attempt to reclaim his legacy, or is it a genuine evolution of his voice? A detail that I find especially interesting is that Elordi and Johansson were his first choices from the beginning. That speaks volumes about his confidence in their ability to carry the weight of his narrative, but it also hints at a desire to avoid the pitfalls of casting compromises. If this deal closes, the film could start shooting later this year, which is both exciting and terrifying. How do you make a thriller that feels fresh when the world is already saturated with horror remakes and reboots? That’s the challenge Aster faces, and it’s one that could define his next chapter.
Meanwhile, Elordi is juggling two high-stakes projects. His role in Ridley Scott’s The Dog Stars promises a stark contrast to the psychological horrors of Scapegoat. Here, he’s playing Hig, a post-apocalyptic pilot navigating a world where survival is a daily battle. Scott, known for his grandiose epics like Gladiator and Alien, has called this his best work—a claim he’s made before, most notably about Gladiator II. What this really suggests is that Scott is chasing immortality through his films, and Elordi is being asked to carry that torch. But how does a young actor like Elordi, who’s still finding his footing in leading roles, handle the pressure of being part of a director’s legacy? It’s a tightrope walk. On one hand, The Dog Stars could be a breakout moment for him; on the other, it risks being overshadowed by the buzz around Scapegoat. The irony isn’t lost on me: Elordi is being cast as both the savior of a dying world and the protagonist of a director’s attempt to reclaim relevance. It’s a dual role that demands versatility, and I’m curious to see how he balances the emotional weight of these projects without burning out.
Looking at the bigger picture, the pairing of Elordi and Johansson in Scapegoat feels like a calculated move by A24 to capitalize on their appeal. A24 has mastered the art of blending auteur filmmaking with mainstream star power, and this project is a textbook example of that strategy. But what’s fascinating is how this dynamic plays into the current state of horror cinema. The genre is no longer confined to slasher films or jump scares—it’s becoming a playground for psychological depth, existential dread, and moral ambiguity. Aster’s work has always leaned into this trend, but Scapegoat might push it further. Could this be the moment when horror fully embraces the complexities of modern trauma, or will it fall back into the same tropes that made Hereditary feel groundbreaking? One thing is certain: the film’s success will depend on whether Aster can craft a story that feels both intimate and epic, personal and universal. And if he succeeds, it could redefine what horror can be in the 2020s. If he fails, it might just be another footnote in the long, winding road of his career.
